CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 8-K Event Delisting notice
- 8-K/A Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Commercial Officer gave up 19,998 shares (to pay taxes)
- 4 Open-market buy Director bought 10,000 shares at $1.17 ($11,650)
- 4 Open-market buy Director bought 5,000 shares at $1.20 ($5,990)
- 4 Open-market buy Director bought 8,140 shares at $1.31 ($10,663)
- 4 Open-market buy Chief Commercial Officer bought 18,180 shares at $1.14 ($20,725)
- 4 Open-market buy Chief Financial Officer bought 24,500 shares at $1.03 ($25,235)
- 4 Open-market buy Chief Executive Officer bought 50,000 shares at $1.03 ($51,500)
- 4 Open-market buy General Counsel and Secretary bought 10,000 shares at $1.03 ($10,250)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
Page 13 of 41 · 802 filings